Structural and functional studies about Xylellain, the cysteine protease from bacterium

Author(s)

Aline Regis Faro

• Document type: Master's Dissertation
• Press: São Carlos.
• Institution: Universidade de São Paulo (USP). Instituto de Física de São Carlos (IFSC/BT)
• Defense date: 2008-07-16

Examining board members

Glaucius Oliva; Fábio Cesar Gozzo; Ricardo De Marco

• Advisor: Glaucius Oliva

Abstract

Xylella fastidiosa is a Gram-negative bacterium which infects the plant xylem system causing in many cases precocious maturation and diminution of fruits. It is responsible for economically important plant diseases, such as the Citrus Variegated Chlorosis (CVC). Proteases might be involved in the infection process by disrupting plant tissue. Xylellain is a cysteine protease which is differently expressed in strain pathogen and non-pathogen of X. fastidiosa. The 3D structure of xylellain was solved by our group and structural studies show that this protein has a proenzyme form and a ribonucleotideo close to the amine terminal region. Our hypothesis is that protein-nucleotide interactions are related to xylellains activation mechanism. To evaluate the influence of the nucleotide in the functional activity of enzyme, point mutations in aminoacids which interact directly with this ribonucleotide were carried out. The point mutations are phenylalanine 45 (F45) and arginine 43 (R43), individually mutated for alanine (A) residues. One way to quantify the changes caused by the alteration of a nucleotide is the direct comparison between the kinetic enzyme assays of native and mutant proteins. Greater variations between the values of Km than in the values of catalytic efficiency were observed. This suggests that the speed of production varied by enzyme-substrate. However the mutations caused little change on the ability of the protease to catalyze the reaction. This result is in agreement with the hypothesis that the nucleotide provides the structural support for the hinge formation on the N-terminal domain, thus directing the inhibitory peptide inside the active site of the enzyme. Therefore, the nucleotide may be exerting regulatory functions in vivo, possibly in the folding or activation of the protein and performance of catalytic function. (AU)